Full Circles Therapeutics Inc.

Full Circles Therapeutics is a pioneering company in the Biotechnology and Health Care industries, based in the United States. The company's slogan, "Genome Engineering Comes Full Circle," encapsulates its mission to harness revolutionary, virus-free technology for DNA reading and writing. Full Circles Therapeutics is at the forefront of transforming genome engineering with its unique, nonviral, targeted genomic integration technology, focusing on treating genetic diseases and cancer. The company's GATALYST platform is a game-changer, delivering circular, single-stranded DNA for integration into genomic safe harbors (GSH) in disease-relevant cell types, without limitations on the size of the donor DNA sequence. This targeted genome engineering approach is dedicated to discovering, developing, and manufacturing novel and curative genomic therapies. Full Circles Therapeutics aims to bridge the gap between technology and treatment, bringing gene editing full circle to pave the way for a brighter future for patients and their families. With a clear focus on impactful innovation, Full Circles Therapeutics presents an exciting opportunity for investment as it seeks to revolutionize the treatment of genetic diseases and cancer through its cutting-edge technology.